{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:15:00Z","timestamp":1772165700182,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shin Kong Wu Ho-Su Memorial Hospital and National Yang Ming Chiao Tung Uni-versity in Taiwan","award":["109GB006-2"],"award-info":[{"award-number":["109GB006-2"]}]},{"DOI":"10.13039\/501100004319","name":"Shin-Kong Wu Ho-Su Memorial Hospital","doi-asserted-by":"crossref","award":["2023SKHADR036"],"award-info":[{"award-number":["2023SKHADR036"]}],"id":[{"id":"10.13039\/501100004319","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04145-9","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T13:23:39Z","timestamp":1745587419000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The protective effects of insulin on the developing of dementia in chronic kidney disease patients with hypertension and diabetes: a population-based nationwide study"],"prefix":"10.1186","volume":"26","author":[{"given":"Yun-Yi","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Hsien","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Wei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Tong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Hsien","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"4145_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-981-13-8871-2_1","volume":"1165","author":"JC Lv","year":"2019","unstructured":"Lv JC, Zhang LX. Prevalence and disease burden of chronic kidney disease. Adv Exp Med Biol. 2019;1165:3\u201315.","journal-title":"Adv Exp Med Biol"},{"issue":"10225","key":"4145_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBDCKD Collaboration","year":"2020","unstructured":"Collaboration GBDCKD. Global, regional, and National burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709\u201333.","journal-title":"Lancet"},{"issue":"3","key":"4145_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000491708","volume":"140","author":"MH Tsai","year":"2018","unstructured":"Tsai MH, Hsu CY, Lin MY, Yen MF, Chen HH, Chiu YH, Hwang SJ. Incidence, prevalence, and duration of chronic kidney disease in Taiwan: results from a Community-Based screening program of 106,094 individuals. Nephron. 2018;140(3):175\u201384.","journal-title":"Nephron"},{"key":"4145_CR4","doi-asserted-by":"crossref","unstructured":"Johansen KL, Chertow GM, Foley RN, Gilbertson DT, Herzog CA, Ishani A, Israni AK, Ku E, Kurella Tamura M, Li S, et al. Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2021;77(4 Suppl 1):A7\u20138. US Renal Data System 2020 Annual Data Report:.","DOI":"10.1053\/j.ajkd.2021.01.002"},{"issue":"11","key":"4145_CR5","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","volume":"143","author":"J Jankowski","year":"2021","unstructured":"Jankowski J, Floege J, Fliser D, Bohm M, Marx N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation. 2021;143(11):1157\u201372.","journal-title":"Circulation"},{"issue":"16","key":"4145_CR6","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1212\/WNL.0000000000009301","volume":"94","author":"MS Korsnes","year":"2020","unstructured":"Korsnes MS, Winkler AS. Global, regional, and National burden of dementia, 1990\u20132016: predictions need local calibration. Neurology. 2020;94(16):718\u20139.","journal-title":"Neurology"},{"issue":"2","key":"4145_CR7","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"GBDDF Collaborators","year":"2022","unstructured":"Collaborators GBDDF. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. Lancet Public Health. 2022;7(2):e105\u201325.","journal-title":"Lancet Public Health"},{"issue":"16","key":"4145_CR8","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/jama.2019.4782","volume":"322","author":"Z Arvanitakis","year":"2019","unstructured":"Arvanitakis Z, Shah RC, Bennett DA. Diagnosis and management of dementia. Rev JAMA. 2019;322(16):1589\u201399.","journal-title":"Rev JAMA"},{"issue":"1","key":"4145_CR9","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12875-021-01461-5","volume":"22","author":"B Fernandes","year":"2021","unstructured":"Fernandes B, Goodarzi Z, Holroyd-Leduc J. Optimizing the diagnosis and management of dementia within primary care: a systematic review of systematic reviews. BMC Fam Pract. 2021;22(1):166.","journal-title":"BMC Fam Pract"},{"key":"4145_CR10","volume-title":"Assessment, management and support for people living with dementia and their carers","author":"Dementia","year":"2018","unstructured":"Dementia. Assessment, management and support for people living with dementia and their carers. London: National Institute for Health and Care Excellence (NICE); 2018."},{"issue":"2","key":"4145_CR11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1212\/WNL.0000000000003482","volume":"88","author":"K Deckers","year":"2017","unstructured":"Deckers K, Camerino I, van Boxtel MP, Verhey FR, Irving K, Brayne C, Kivipelto M, Starr JM, Yaffe K, de Leeuw PW, et al. Dementia risk in renal dysfunction: A systematic review and meta-analysis of prospective studies. Neurology. 2017;88(2):198\u2013208.","journal-title":"Neurology"},{"issue":"23","key":"4145_CR12","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1212\/WNL.0b013e31823b4765","volume":"77","author":"C Helmer","year":"2011","unstructured":"Helmer C, Stengel B, Metzger M, Froissart M, Massy ZA, Tzourio C, Berr C, Dartigues JF. Chronic kidney disease, cognitive decline, and incident dementia: the 3\u00a0C study. Neurology. 2011;77(23):2043\u201351.","journal-title":"Neurology"},{"issue":"3","key":"4145_CR13","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1016\/j.amepre.2021.03.005","volume":"61","author":"JP Barrett","year":"2021","unstructured":"Barrett JP, Olivari BS, Price AB, Taylor CA. Cognitive decline and dementia risk reduction: promoting healthy lifestyles and blood pressure control. Am J Prev Med. 2021;61(3):e157\u201360.","journal-title":"Am J Prev Med"},{"issue":"5","key":"4145_CR14","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1161\/HYPERTENSIONAHA.119.14388","volume":"75","author":"D Kim","year":"2020","unstructured":"Kim D, Yang PS, Jang E, Tae Yu H, Kim TH, Uhm JS, Kim JY, Sung JH, Pak HN, Lee MH, et al. Blood pressure control and dementia risk in midlife patients with atrial fibrillation. Hypertension. 2020;75(5):1296\u2013304.","journal-title":"Hypertension"},{"issue":"19","key":"4145_CR15","doi-asserted-by":"publisher","first-page":"e009992","DOI":"10.1161\/JAHA.118.009992","volume":"7","author":"E Ku","year":"2018","unstructured":"Ku E, McCulloch CE, Vittinghoff E, Lin F, Johansen KL. Use of antihypertensive agents and association with risk of adverse outcomes in chronic kidney disease: focus on angiotensin-Converting enzyme inhibitors and angiotensin receptor blockers. J Am Heart Assoc. 2018;7(19):e009992.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"4145_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1001\/jamainternmed.2013.12700","volume":"174","author":"TW Hsu","year":"2014","unstructured":"Hsu TW, Liu JS, Hung SC, Kuo KL, Chang YK, Chen YC, Hsu CC, Tarng DC. Renoprotective effect of renin-angiotensin-aldosterone system Blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia. JAMA Intern Med. 2014;174(3):347\u201354.","journal-title":"JAMA Intern Med"},{"key":"4145_CR17","doi-asserted-by":"crossref","unstructured":"Chen YH, Chen YY, Fang YW, Tsai MH. Protective effects of angiotensin receptor blockers on the incidence of dementia in patients with chronic kidney disease: A Population-Based nationwide study. J Clin Med 2021, 10(21).","DOI":"10.3390\/jcm10215175"},{"key":"4145_CR18","doi-asserted-by":"publisher","first-page":"b5465","DOI":"10.1136\/bmj.b5465","volume":"340","author":"NC Li","year":"2010","unstructured":"Li NC, Lee A, Whitmer RA, Kivipelto M, Lawler E, Kazis LE, Wolozin B. Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ. 2010;340:b5465.","journal-title":"BMJ"},{"key":"4145_CR19","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3389\/fphar.2018.00440","volume":"9","author":"AK Gebre","year":"2018","unstructured":"Gebre AK, Altaye BM, Atey TM, Tuem KB, Berhe DF. Targeting Renin-Angiotensin system against Alzheimer\u2019s disease. Front Pharmacol. 2018;9:440.","journal-title":"Front Pharmacol"},{"issue":"7","key":"4145_CR20","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.2337\/db14-0568","volume":"63","author":"A Kleinridders","year":"2014","unstructured":"Kleinridders A, Ferris HA, Cai W, Kahn CR. Insulin action in brain regulates systemic metabolism and brain function. Diabetes. 2014;63(7):2232\u201343.","journal-title":"Diabetes"},{"key":"4145_CR21","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3389\/fnagi.2019.00236","volume":"11","author":"J Folch","year":"2019","unstructured":"Folch J, Olloquequi J, Ettcheto M, Busquets O, Sanchez-Lopez E, Cano A, Espinosa-Jimenez T, Garcia ML, Beas-Zarate C, Casadesus G, et al. The involvement of peripheral and brain insulin resistance in late onset Alzheimer\u2019s dementia. Front Aging Neurosci. 2019;11:236.","journal-title":"Front Aging Neurosci"},{"issue":"9","key":"4145_CR22","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","volume":"19","author":"D Kellar","year":"2020","unstructured":"Kellar D, Craft S. Brain insulin resistance in Alzheimer\u2019s disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol. 2020;19(9):758\u201366.","journal-title":"Lancet Neurol"},{"issue":"9","key":"4145_CR23","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1001\/jamaneurol.2020.1840","volume":"77","author":"S Craft","year":"2020","unstructured":"Craft S, Raman R, Chow TW, Rafii MS, Sun CK, Rissman RA, Donohue MC, Brewer JB, Jenkins C, Harless K, et al. Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and alzheimer disease dementia: A randomized clinical trial. JAMA Neurol. 2020;77(9):1099\u2013109.","journal-title":"JAMA Neurol"},{"issue":"2","key":"4145_CR24","doi-asserted-by":"publisher","first-page":"e0212293","DOI":"10.1371\/journal.pone.0212293","volume":"14","author":"G Weinstein","year":"2019","unstructured":"Weinstein G, Davis-Plourde KL, Conner S, Himali JJ, Beiser AS, Lee A, Rawlings AM, Sedaghat S, Ding J, Moshier E, et al. Association of Metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer\u2019s disease: pooled analysis from 5 cohorts. PLoS ONE. 2019;14(2):e0212293.","journal-title":"PLoS ONE"},{"issue":"1","key":"4145_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/gerona\/glu314","volume":"71","author":"S Maimaiti","year":"2016","unstructured":"Maimaiti S, Anderson KL, DeMoll C, Brewer LD, Rauh BA, Gant JC, Blalock EM, Porter NM, Thibault O. Intranasal insulin improves Age-Related cognitive deficits and reverses electrophysiological correlates of brain aging. J Gerontol Biol Sci Med Sci. 2016;71(1):30\u20139.","journal-title":"J Gerontol Biol Sci Med Sci"},{"key":"4145_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2147\/CLEP.S196293","volume":"11","author":"CY Hsieh","year":"2019","unstructured":"Hsieh CY, Su CC, Shao SC, Sung SF, Lin SJ, Kao Yang YH, Lai EC. Taiwan\u2019s National health insurance research database: past and future. Clin Epidemiol. 2019;11:349\u201358.","journal-title":"Clin Epidemiol"},{"issue":"3","key":"4145_CR27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s40273-017-0597-y","volume":"36","author":"MV Bjarnadottir","year":"2018","unstructured":"Bjarnadottir MV, Czerwinski D, Onukwugha E. Sensitivity of the medication possession ratio to modelling decisions in large claims databases. PharmacoEconomics. 2018;36(3):369\u201380.","journal-title":"PharmacoEconomics"},{"issue":"7","key":"4145_CR28","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.2215\/CJN.10301016","volume":"12","author":"JY Hsu","year":"2017","unstructured":"Hsu JY, Roy JA, Xie D, Yang W, Shou H, Anderson AH, Landis JR, Jepson C, Wolf M, Isakova T, et al. Statistical methods for cohort studies of CKD: survival analysis in the setting of competing risks. Clin J Am Soc Nephrol. 2017;12(7):1181\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"4145_CR29","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41574-021-00498-x","volume":"17","author":"T Scherer","year":"2021","unstructured":"Scherer T, Sakamoto K, Buettner C. Brain insulin signalling in metabolic homeostasis and disease. Nat Rev Endocrinol. 2021;17(8):468\u201383.","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"4145_CR30","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s00125-009-1323-x","volume":"52","author":"WL Xu","year":"2009","unstructured":"Xu WL, von Strauss E, Qiu CX, Winblad B, Fratiglioni L. Uncontrolled diabetes increases the risk of Alzheimer\u2019s disease: a population-based cohort study. Diabetologia. 2009;52(6):1031\u20139.","journal-title":"Diabetologia"},{"key":"4145_CR31","doi-asserted-by":"crossref","unstructured":"Verdile G, Keane KN, Cruzat VF, Medic S, Sabale M, Rowles J, Wijesekara N, Martins RN, Fraser PE, Newsholme P. Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer\u2019s Disease. Mediators Inflamm 2015, 2015:105828.","DOI":"10.1155\/2015\/105828"},{"issue":"1","key":"4145_CR32","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41598-017-18998-0","volume":"8","author":"SH Kong","year":"2018","unstructured":"Kong SH, Park YJ, Lee JY, Cho NH, Moon MK. Insulin resistance is associated with cognitive decline among older Koreans with normal baseline cognitive function: A prospective Community-Based cohort study. Sci Rep. 2018;8(1):650.","journal-title":"Sci Rep"},{"issue":"6","key":"4145_CR33","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2337\/dc16-2001","volume":"40","author":"LL Ekblad","year":"2017","unstructured":"Ekblad LL, Rinne JO, Puukka P, Laine H, Ahtiluoto S, Sulkava R, Viitanen M, Jula A. Insulin resistance predicts cognitive decline: an 11-Year Follow-up of a nationally representative adult population sample. Diabetes Care. 2017;40(6):751\u20138.","journal-title":"Diabetes Care"},{"key":"4145_CR34","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3389\/fnins.2018.00830","volume":"12","author":"LSS Ferreira","year":"2018","unstructured":"Ferreira LSS, Fernandes CS, Vieira MNN, De Felice FG. Insulin resistance in Alzheimer\u2019s disease. Front Neurosci. 2018;12:830.","journal-title":"Front Neurosci"},{"issue":"1\u20132","key":"4145_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.mce.2012.05.017","volume":"378","author":"R Muniyappa","year":"2013","unstructured":"Muniyappa R, Yavuz S. Metabolic actions of angiotensin II and insulin: a microvascular endothelial balancing act. Mol Cell Endocrinol. 2013;378(1\u20132):59\u201369.","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"4145_CR36","doi-asserted-by":"publisher","first-page":"e12934","DOI":"10.1111\/jne.12934","volume":"33","author":"M Hallschmid","year":"2021","unstructured":"Hallschmid M. Intranasal insulin. J Neuroendocrinol. 2021;33(4):e12934.","journal-title":"J Neuroendocrinol"},{"issue":"7","key":"4145_CR37","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s00415-018-8768-0","volume":"265","author":"KI Avgerinos","year":"2018","unstructured":"Avgerinos KI, Kalaitzidis G, Malli A, Kalaitzoglou D, Myserlis PG, Lioutas VA. Intranasal insulin in Alzheimer\u2019s dementia or mild cognitive impairment: a systematic review. J Neurol. 2018;265(7):1497\u2013510.","journal-title":"J Neurol"},{"issue":"1","key":"4145_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13098-022-00799-9","volume":"14","author":"L Huang","year":"2022","unstructured":"Huang L, Zhu M, Ji J. Association between hypoglycemia and dementia in patients with diabetes: a systematic review and meta-analysis of 1.4 million patients. Diabetol Metab Syndr. 2022;14(1):31.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"4145_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.6061\/clinics\/2016(01)08","volume":"71","author":"CC Betonico","year":"2016","unstructured":"Betonico CC, Titan SM, Correa-Giannella ML, Nery M, Queiroz M. Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control. Clin (Sao Paulo). 2016;71(1):47\u201353.","journal-title":"Clin (Sao Paulo)"},{"key":"4145_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.diabres.2017.02.032","volume":"127","author":"R Rajput","year":"2017","unstructured":"Rajput R, Sinha B, Majumdar S, Shunmugavelu M, Bajaj S. Consensus statement on insulin therapy in chronic kidney disease. Diabetes Res Clin Pract. 2017;127:10\u201320.","journal-title":"Diabetes Res Clin Pract"},{"key":"4145_CR41","doi-asserted-by":"publisher","first-page":"117955141879225","DOI":"10.1177\/1179551418792257","volume":"11","author":"CE Kosmas","year":"2018","unstructured":"Kosmas CE, Silverio D, Tsomidou C, Salcedo MD, Montan PD, Guzman E. The impact of insulin resistance and chronic kidney disease on inflammation and cardiovascular disease. Clin Med Insights Endocrinol Diabetes. 2018;11:1179551418792257.","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"issue":"Suppl 2","key":"4145_CR42","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1016\/j.jfma.2019.06.001","volume":"118","author":"CH Chu","year":"2019","unstructured":"Chu CH, Hsu CC, Lin SY, Chuang LM, Liu JS, Tu ST. Trends in antidiabetic medical treatment from 2005 to 2014 in Taiwan. J Formos Med Assoc. 2019;118(Suppl 2):S74\u201382.","journal-title":"J Formos Med Assoc"},{"issue":"10248","key":"4145_CR43","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, et al. Dementia prevention, intervention, and care: 2020 report of the lancet commission. Lancet. 2020;396(10248):413\u201346.","journal-title":"Lancet"},{"key":"4145_CR44","doi-asserted-by":"crossref","unstructured":"Timsans J, Palom\u00e4ki A, Kauppi M. Gout and Hyperuricemia: A Narrative Review of Their Comorbidities and Clinical Implications. J Clin Med. 2024:13(24).","DOI":"10.3390\/jcm13247616"},{"issue":"4","key":"4145_CR45","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1021\/cn500363g","volume":"6","author":"P Kaur","year":"2015","unstructured":"Kaur P, Muthuraman A, Kaur M. The implications of angiotensin-converting enzymes and their modulators in neurodegenerative disorders: current and future perspectives. ACS Chem Neurosci. 2015;6(4):508\u201321.","journal-title":"ACS Chem Neurosci"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04145-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04145-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04145-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T15:02:37Z","timestamp":1745593357000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04145-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4145"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04145-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4329846\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"26 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol adhered to the International Conference on Harmonization Good Clinical Practice guidelines, the Declaration of Helsinki, and applicable laws for noninterventional and observational studies. This study was approved by Shin Kong Wu Ho-Su Memorial Hospital\u2019s Ethics Review Board (IRB number: 20200806R) and the informed consent was waived because all personal information was deidentified in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"211"}}